Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
25 02 2022
Historique:
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 12 3 2022
Statut: ppublish

Résumé

Treatment of bacterial infections currently focuses on choosing an antibiotic that matches a pathogen's susceptibility, with less attention paid to the risk that even susceptibility-matched treatments can fail as a result of resistance emerging in response to treatment. Combining whole-genome sequencing of 1113 pre- and posttreatment bacterial isolates with machine-learning analysis of 140,349 urinary tract infections and 7365 wound infections, we found that treatment-induced emergence of resistance could be predicted and minimized at the individual-patient level. Emergence of resistance was common and driven not by de novo resistance evolution but by rapid reinfection with a different strain resistant to the prescribed antibiotic. As most infections are seeded from a patient's own microbiota, these resistance-gaining recurrences can be predicted using the patient's past infection history and minimized by machine learning-personalized antibiotic recommendations, offering a means to reduce the emergence and spread of resistant pathogens.

Identifiants

pubmed: 35201862
doi: 10.1126/science.abg9868
pmc: PMC7612469
mid: EMS143775
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

889-894

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204684
Pays : United Kingdom
Organisme : European Research Council
ID : 281891
Pays : International
Organisme : NIGMS NIH HHS
ID : R01 GM081617
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

J Infect Dis. 2001 Mar 1;183 Suppl 1:S1-4
pubmed: 11171002
PLoS Biol. 2008 Nov 18;6(11):e280
pubmed: 19018661
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Infect Chemother. 2017 Dec;49(4):301-325
pubmed: 29299899
Can J Infect Dis Med Microbiol. 2008 Mar;19(2):173-84
pubmed: 19352449
Curr Opin Infect Dis. 2015 Jun;28(3):253-8
pubmed: 25887613
Sci Transl Med. 2016 Jun 15;8(343):343ra81
pubmed: 27306663
J Antimicrob Chemother. 2003 Apr;51(4):963-70
pubmed: 12654756
Clin Infect Dis. 1996 Jan;22(1):91-9
pubmed: 8824972
CMAJ. 1999 May 18;160(10):1436-40
pubmed: 10352632
J Urol. 1995 Jan;153(1):117-20
pubmed: 7966741
Infection. 2008 Feb;36(1):41-5
pubmed: 18193386
Int J Antimicrob Agents. 1994 Jun;4(2):83-8
pubmed: 18611593
Science. 2016 Apr 29;352(6285):535-8
pubmed: 27126035
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
Clin Infect Dis. 2002 Apr 15;34(8):1061-6
pubmed: 11914994
Nat Commun. 2019 Aug 13;10(1):3643
pubmed: 31409795
Nat Commun. 2019 Dec 4;10(1):5521
pubmed: 31797927
Lancet. 2005 Feb 12-18;365(9459):579-87
pubmed: 15708101
J Med Microbiol. 2014 Apr;63(Pt 4):582-589
pubmed: 24464694
Nat Genet. 2011 Dec 18;44(1):101-5
pubmed: 22179135
J Antimicrob Chemother. 2017 Oct 1;72(10):2764-2768
pubmed: 29091202
Curr Urol Rep. 2013 Oct;14(5):448-56
pubmed: 23832844
Clin Infect Dis. 2004 Jul 1;39(1):75-80
pubmed: 15206056
Clin Infect Dis. 2011 Mar 1;52(5):e103-20
pubmed: 21292654
Appl Microbiol Biotechnol. 2011 Nov;92(3):479-97
pubmed: 21904817
BMC Microbiol. 2008 Mar 06;8:43
pubmed: 18325110
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
Am J Med. 2003 Oct 1;115(5):358-64
pubmed: 14553870
J Infect Dis. 2004 May 1;189(9):1565-73
pubmed: 15116291
BMC Infect Dis. 2015 Jun 09;15:224
pubmed: 26054866
Am J Med. 2008 Oct;121(10):876-84
pubmed: 18823859
Clin Infect Dis. 2020 Feb 14;70(5):937-939
pubmed: 31271206
Nat Med. 2019 Jul;25(7):1143-1152
pubmed: 31273328

Auteurs

Mathew Stracy (M)

Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Department of Biochemistry, University of Oxford, Oxford, UK.

Olga Snitser (O)

Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.

Idan Yelin (I)

Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.

Yara Amer (Y)

Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.

Miriam Parizade (M)

Maccabi Mega Lab, Maccabi Healthcare Services, Tel Aviv, Israel.

Rachel Katz (R)

Maccabi Mega Lab, Maccabi Healthcare Services, Tel Aviv, Israel.

Galit Rimler (G)

Maccabi Mega Lab, Maccabi Healthcare Services, Tel Aviv, Israel.

Tamar Wolf (T)

Maccabi Mega Lab, Maccabi Healthcare Services, Tel Aviv, Israel.

Esma Herzel (E)

Maccabitech, Maccabi Healthcare Services, Tel Aviv, Israel.

Gideon Koren (G)

Maccabitech, Maccabi Healthcare Services, Tel Aviv, Israel.

Jacob Kuint (J)

Maccabitech, Maccabi Healthcare Services, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Betsy Foxman (B)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Gabriel Chodick (G)

Maccabitech, Maccabi Healthcare Services, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Varda Shalev (V)

Maccabitech, Maccabi Healthcare Services, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Roy Kishony (R)

Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Department of Computer Science, Technion-Israel Institute of Technology, Haifa, Israel.
Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering, Technion-Israel Institute of Technology, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH